The Effect of CYP1A1 and CYP1A2 Polymorphisms on Gastric Cancer Risk Among Different Ethnicities: a Systematic Review and Meta-analysis

Overview

Journal Tumour Biol

Publisher Sage Publications

Specialty Oncology

Date 2014 Jan 21

PMID 24443269

Citations 7

Authors

Huiping Xue

Yan Lu

Zeyun Xue

Bing Lin

Jinxian Chen

Feng Tang

Gang Huang

Affiliations

Soon will be listed here.

Abstract

Potential Cytochrome P450s (CYPs) 1A1 MspI, 1A1 Ile462Val, 1A2*1 F, and/or 1A2*1C polymorphisms have been implicated in gastric cancer risk among different ethnicities. We aimed to explore the effect of CYP 1A1 MspI, 1A1 Ile462Val, 1A2*1 F, and/or 1A2*1C polymorphisms on the susceptibility to gastric cancer among different ethnicities through a systematic review and meta-analysis. Each initially included article was scored for quality appraisal. Desirable data were extracted and registered into databases. A number of 11 studies were ultimately eligible for the meta-analysis of CYP1A1 MspI polymorphism, eight studies for the meta-analysis of 1A1 Ile462Val polymorphism, and two studies for the meta-analysis of 1A2*1 F polymorphism. None of genetic model was evidently suggested, and thus all the genetic models were presented. Potential sources of heterogeneity were sought out via subgroup and sensitivity analyses, and publication biases were estimated. In our meta-analysis, significant results could be found in mutational heterozygous CT genotype, compared with wild TT genotype, among large sample size subgroup for CYP1A1 MspI polymorphism. Regarding CYP1A1 Ile462Val polymorphism, no statistically significant results could be found. For CYP1A2*1 F polymorphism, mutational heterozygous AC genotype, compared with wild-type AA, has deleterious effects, whereas mutational homozygous CC genotype, compared with mutational heterozygous type AC, has protective effects but lacks statistically significant difference despite its a proximity to 0.05. Combined mutational homozygous CC genotype and wild-type homozygous AA, compared with mutational heterozygous AC genotype, has protective effects. Our meta-analysis suggests no associations between CYP1A1 Ile462Val polymorphism and gastric cancer, but possible associations between CYP1A1 MspI and CYP1A2*1 F polymorphisms and gastric cancer, which needs to be further reinforced or refuted among different ethnicities in well-designed large-scale high-quality studies.

Citing Articles

Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes in Gastric Cancer.

Wei X, Luo T, Li J, Xue Z, Wang Y, Zhang Y Front Mol Biosci. 2021; 8:691143.

PMID: 34277706 PMC: 8277939. DOI: 10.3389/fmolb.2021.691143.

Extrahepatic cytochrome P450 epoxygenases: pathophysiology and clinical significance in human gastrointestinal cancers.

Pidkovka N, Rachkevych O, Belkhiri A Oncotarget. 2021; 12(4):379-391.

PMID: 33659048 PMC: 7899545. DOI: 10.18632/oncotarget.27893.

Genetic polymorphisms and gastric cancer risk: a comprehensive review synopsis from meta-analysis and genome-wide association studies.

Tian J, Liu G, Zuo C, Liu C, He W, Chen H Cancer Biol Med. 2019; 16(2):361-389.

PMID: 31516756 PMC: 6713634. DOI: 10.20892/j.issn.2095-3941.2018.0290.

Association between polymorphisms in the genes, and smoking, alcohol and upper digestive tract carcinomas in a high-incidence area of northern China.

Zhao F, Su J, Lun S, Hou Y, Duan L, Wang N Oncol Lett. 2019; 18(2):1267-1277.

PMID: 31423187 PMC: 6607096. DOI: 10.3892/ol.2019.10455.

Lack of association between polymorphisms in the CYP1A2 gene and risk of cancer: evidence from meta-analyses.

Vukovic V, Ianuale C, Leoncini E, Pastorino R, Gualano M, Amore R BMC Cancer. 2016; 16:83.

PMID: 26865042 PMC: 4750358. DOI: 10.1186/s12885-016-2096-5.

References

Lee K, Caceres D, Varela N, Csendes D A, Rios R H, Quinones S L . [Allelic variants of cytochrome P4501A1 (CYP1A1), glutathione S transferase M1 (GSTM1) polymorphisms and their association with smoking and alcohol consumption as gastric cancer susceptibility biomarkers]. Rev Med Chil. 2006; 134(9):1107-15. DOI: 10.4067/s0034-98872006000900004. View

Constable A, Varga N, Josephy P, Guy P, Turesky R . Evaluation of Escherichia coli DJ4309 expressing human P450 1A2 in mutagenicity testing of complex food mixtures. Mutat Res. 1999; 442(2):79-87. DOI: 10.1016/s1383-5718(99)00066-2. View

Boccia S, Sayed-Tabatabaei F, Persiani R, Gianfagna F, Rausei S, Arzani D . Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population. BMC Cancer. 2007; 7:206. PMC: 2194718. DOI: 10.1186/1471-2407-7-206. View

Gonzalez A, Ramirez V, Cuenca P, Sierra R . [Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility]. Rev Biol Trop. 2007; 52(3):591-600. View

Roth M, Abnet C, Johnson L, Mark S, Dong Z, Taylor P . Polymorphic variation of Cyp1A1 is associated with the risk of gastric cardia cancer: a prospective case-cohort study of cytochrome P-450 1A1 and GST enzymes. Cancer Causes Control. 2005; 15(10):1077-83. DOI: 10.1007/s10552-004-2233-3. View

Xue H, Ni P, Lin B, Xu H, Huang G . X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis. Am J Epidemiol. 2011; 173(4):363-75. DOI: 10.1093/aje/kwq378. View

McManus M, Burgess W, Veronese M, Huggett A, Quattrochi L, Tukey R . Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Cancer Res. 1990; 50(11):3367-76. View

Suzuki S, Muroishi Y, Nakanishi I, Oda Y . Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer. J Gastroenterol. 2004; 39(3):220-30. DOI: 10.1007/s00535-003-1281-x. View

Xue H, Wang Y, Lin B, An J, Chen L, Chen J . A meta-analysis of interleukin-10 -592 promoter polymorphism associated with gastric cancer risk. PLoS One. 2012; 7(7):e39868. PMC: 3409223. DOI: 10.1371/journal.pone.0039868. View

10.

Shen J, Wang R, Xu Y, Wang L, Wang X . Interaction models of CYP1A1, GSTM1 polymorphisms and tobacco smoking in intestinal gastric cancer. World J Gastroenterol. 2005; 11(38):6056-60. PMC: 4436735. DOI: 10.3748/wjg.v11.i38.6056. View

11.

Malik M, Upadhyay R, Mittal R, Zargar S, Modi D, Mittal B . Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir Valley. J Gastrointest Cancer. 2009; 40(1-2):26-32. DOI: 10.1007/s12029-009-9072-0. View

12.

Nan H, Song Y, Yun H, Park J, Kim H . Effects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer. World J Gastroenterol. 2005; 11(25):3834-41. PMC: 4504881. DOI: 10.3748/wjg.v11.i25.3834. View

13.

Han F, Wang X, Wang X, Luo Y, Li W . Meta-analysis of the association of CYP1A1 polymorphisms with gastric cancer susceptibility and interaction with tobacco smoking. Mol Biol Rep. 2012; 39(8):8335-44. DOI: 10.1007/s11033-012-1683-z. View

14.

Olivieri E, da Silva S, Mendonca F, Urata Y, Vidal D, Faria M . CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients. Oral Oncol. 2009; 45(9):e73-9. DOI: 10.1016/j.oraloncology.2009.03.004. View

15.

Xue H, Lin B, Ni P, Xu H, Huang G . Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis. J Gastroenterol Hepatol. 2010; 25(10):1604-17. DOI: 10.1111/j.1440-1746.2010.06428.x. View

16.

Li H, Chen X, Li H . Polymorphism of CYPIA1 and GSTM1 genes associated with susceptibility of gastric cancer in Shandong Province of China. World J Gastroenterol. 2005; 11(37):5757-62. PMC: 4479672. DOI: 10.3748/wjg.v11.i37.5757. View

17.

Xue H, Liu J, Lin B, Wang Z, Sun J, Huang G . A meta-analysis of interleukin-8 -251 promoter polymorphism associated with gastric cancer risk. PLoS One. 2012; 7(1):e28083. PMC: 3261138. DOI: 10.1371/journal.pone.0028083. View

18.

Al-Buheissi S, Cole K, Hewer A, Kumar V, Bryan R, Hudson D . The expression of xenobiotic-metabolizing enzymes in human prostate and in prostate epithelial cells (PECs) derived from primary cultures. Prostate. 2006; 66(8):876-85. DOI: 10.1002/pros.20400. View

19.

Xue H, Lin B, An J, Zhu Y, Huang G . Interleukin-10-819 promoter polymorphism in association with gastric cancer risk. BMC Cancer. 2012; 12:102. PMC: 3384469. DOI: 10.1186/1471-2407-12-102. View

20.

Darazy M, Balbaa M, Mugharbil A, Saeed H, Sidani H, Abdel-Razzak Z . CYP1A1, CYP2E1, and GSTM1 gene polymorphisms and susceptibility to colorectal and gastric cancer among Lebanese. Genet Test Mol Biomarkers. 2011; 15(6):423-9. DOI: 10.1089/gtmb.2010.0206. View